BCV
IHE icon

Banque Cantonale Vaudoise’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Banque Cantonale Vaudoise’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,500
Closed -$2.08M – 904
2025
Q4 		$2.08M Buy
+24,500
New +$1.96M 0.07% 264

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return

Banque Cantonale Vaudoise's IHE Position: Q1 2026 in Review

Banque Cantonale Vaudoise sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2026, closing a stake of 24,500 shares — an estimated $2.08M sold.

Banque Cantonale Vaudoise first reported a position in IHE in Q4 2025 and held it in 1 quarter. The position peaked at $2.08M in Q4 2025. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Banque Cantonale Vaudoise reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 24,500 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $2.08M.
  • Banque Cantonale Vaudoise first reported a position in iShares US Pharmaceuticals ETF in Q4 2025 and held it in 1 quarter.
  • Banque Cantonale Vaudoise's iShares US Pharmaceuticals ETF position peaked at $2.08M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.